| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin filament binding | 8.02e-06 | 227 | 25 | 5 | GO:0051015 | |
| GeneOntologyMolecularFunction | cadherin binding | 5.50e-05 | 339 | 25 | 5 | GO:0045296 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 8.87e-05 | 614 | 25 | 6 | GO:0140657 | |
| GeneOntologyMolecularFunction | actin binding | 2.78e-04 | 479 | 25 | 5 | GO:0003779 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | 3.01e-04 | 1099 | 25 | 7 | GO:0008092 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 7.71e-04 | 599 | 25 | 5 | GO:0050839 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate binding | 8.73e-04 | 35 | 25 | 2 | GO:0043325 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.03e-03 | 38 | 25 | 2 | GO:0000146 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 1.71e-03 | 49 | 25 | 2 | GO:0005547 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.05e-03 | 441 | 25 | 4 | GO:0016887 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 2.59e-03 | 1160 | 25 | 6 | GO:0030674 | |
| GeneOntologyMolecularFunction | protein dimerization activity | 3.13e-03 | 1205 | 25 | 6 | GO:0046983 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 4.08e-03 | 875 | 25 | 5 | GO:0019904 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 5.61e-03 | 1356 | 25 | 6 | GO:0060090 | |
| GeneOntologyMolecularFunction | protein kinase activity | 6.18e-03 | 600 | 25 | 4 | GO:0004672 | |
| GeneOntologyCellularComponent | myofibril | 2.90e-04 | 273 | 25 | 4 | GO:0030016 | |
| GeneOntologyCellularComponent | supramolecular fiber | 3.49e-04 | 1179 | 25 | 7 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 3.64e-04 | 1187 | 25 | 7 | GO:0099081 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 3.65e-04 | 290 | 25 | 4 | GO:0043292 | |
| GeneOntologyCellularComponent | myosin filament | 4.05e-04 | 25 | 25 | 2 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 5.09e-04 | 28 | 25 | 2 | GO:0016460 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 5.25e-04 | 576 | 25 | 5 | GO:0015629 | |
| GeneOntologyCellularComponent | leading edge membrane | 1.95e-03 | 210 | 25 | 3 | GO:0031256 | |
| GeneOntologyCellularComponent | myosin complex | 2.25e-03 | 59 | 25 | 2 | GO:0016459 | |
| GeneOntologyCellularComponent | cell leading edge | 2.74e-03 | 500 | 25 | 4 | GO:0031252 | |
| GeneOntologyCellularComponent | intercalated disc | 2.98e-03 | 68 | 25 | 2 | GO:0014704 | |
| GeneOntologyCellularComponent | sarcomere | 3.16e-03 | 249 | 25 | 3 | GO:0030017 | |
| HumanPheno | Dialeptic seizure | 2.77e-05 | 251 | 5 | 4 | HP:0011146 | |
| HumanPheno | Myoclonic seizure | 3.28e-05 | 262 | 5 | 4 | HP:0032794 | |
| HumanPheno | Epileptic encephalopathy | 1.20e-04 | 119 | 5 | 3 | HP:0200134 | |
| HumanPheno | Focal impaired awareness seizure | 1.43e-04 | 126 | 5 | 3 | HP:0002384 | |
| HumanPheno | Bilateral tonic-clonic seizure | 1.66e-04 | 394 | 5 | 4 | HP:0002069 | |
| Domain | PKK | 1.45e-06 | 2 | 23 | 2 | PF12474 | |
| Domain | PKK | 1.45e-06 | 2 | 23 | 2 | IPR022165 | |
| Domain | Myosin_N | 1.51e-04 | 15 | 23 | 2 | IPR004009 | |
| Domain | Myosin_N | 1.51e-04 | 15 | 23 | 2 | PF02736 | |
| Domain | Myosin_tail_1 | 2.19e-04 | 18 | 23 | 2 | PF01576 | |
| Domain | Myosin_tail | 2.19e-04 | 18 | 23 | 2 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 2.45e-04 | 19 | 23 | 2 | IPR027401 | |
| Domain | - | 2.45e-04 | 19 | 23 | 2 | 4.10.270.10 | |
| Domain | Spectrin | 3.61e-04 | 23 | 23 | 2 | PF00435 | |
| Domain | Spectrin_repeat | 5.77e-04 | 29 | 23 | 2 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 7.04e-04 | 32 | 23 | 2 | IPR018159 | |
| Domain | SPEC | 7.04e-04 | 32 | 23 | 2 | SM00150 | |
| Domain | MYOSIN_MOTOR | 9.93e-04 | 38 | 23 | 2 | PS51456 | |
| Domain | Myosin_head | 9.93e-04 | 38 | 23 | 2 | PF00063 | |
| Domain | Myosin_head_motor_dom | 9.93e-04 | 38 | 23 | 2 | IPR001609 | |
| Domain | MYSc | 9.93e-04 | 38 | 23 | 2 | SM00242 | |
| Domain | - | 1.22e-03 | 391 | 23 | 4 | 2.30.29.30 | |
| Domain | PH_dom-like | 1.68e-03 | 426 | 23 | 4 | IPR011993 | |
| Domain | CH | 2.88e-03 | 65 | 23 | 2 | SM00033 | |
| Domain | P-loop_NTPase | 3.24e-03 | 848 | 23 | 5 | IPR027417 | |
| Domain | CH | 3.33e-03 | 70 | 23 | 2 | PF00307 | |
| Domain | - | 3.42e-03 | 71 | 23 | 2 | 1.10.418.10 | |
| Domain | CH | 3.61e-03 | 73 | 23 | 2 | PS50021 | |
| Domain | CH-domain | 3.81e-03 | 75 | 23 | 2 | IPR001715 | |
| Domain | Kinase-like_dom | 4.00e-03 | 542 | 23 | 4 | IPR011009 | |
| Domain | IQ | 4.43e-03 | 81 | 23 | 2 | SM00015 | |
| Domain | PH | 4.63e-03 | 278 | 23 | 3 | SM00233 | |
| Domain | PH_DOMAIN | 4.68e-03 | 279 | 23 | 3 | PS50003 | |
| Domain | PH_domain | 4.73e-03 | 280 | 23 | 3 | IPR001849 | |
| Domain | EF-hand_7 | 4.87e-03 | 85 | 23 | 2 | PF13499 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 4.49e-08 | 774 | 25 | 8 | 15302935 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 23209304 | ||
| Pubmed | Activation segment dimerization: a mechanism for kinase autophosphorylation of non-consensus sites. | 2.97e-06 | 4 | 25 | 2 | 18239682 | |
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 27919044 | ||
| Pubmed | A genome-wide association study of the Protein C anticoagulant pathway. | 1.39e-05 | 8 | 25 | 2 | 22216198 | |
| Pubmed | 2.59e-05 | 503 | 25 | 5 | 16964243 | ||
| Pubmed | 4.07e-05 | 272 | 25 | 4 | 31010829 | ||
| Pubmed | 4.49e-05 | 14 | 25 | 2 | 28153048 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 4.58e-05 | 1415 | 25 | 7 | 28515276 | |
| Pubmed | 4.81e-05 | 284 | 25 | 4 | 29459677 | ||
| Pubmed | 5.00e-05 | 963 | 25 | 6 | 28671696 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 5.19e-05 | 582 | 25 | 5 | 20467437 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | 5.47e-05 | 1455 | 25 | 7 | 22863883 | |
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 5.92e-05 | 16 | 25 | 2 | 19922871 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 8.56e-05 | 647 | 25 | 5 | 26618866 | |
| Pubmed | 8.94e-05 | 653 | 25 | 5 | 22586326 | ||
| Pubmed | 1.26e-04 | 1139 | 25 | 6 | 36417873 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 1.32e-04 | 1149 | 25 | 6 | 35446349 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 1.44e-04 | 377 | 25 | 4 | 38117590 | |
| Pubmed | 1.72e-04 | 27 | 25 | 2 | 19026994 | ||
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 1.79e-04 | 153 | 25 | 3 | 26365490 | |
| Pubmed | 2.13e-04 | 30 | 25 | 2 | 21575865 | ||
| Pubmed | 2.28e-04 | 31 | 25 | 2 | 21985497 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 2.40e-04 | 807 | 25 | 5 | 30575818 | |
| Pubmed | 2.58e-04 | 33 | 25 | 2 | 36964131 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 3.21e-04 | 1353 | 25 | 6 | 29467282 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 3.23e-04 | 861 | 25 | 5 | 36931259 | |
| Pubmed | 4.48e-04 | 1440 | 25 | 6 | 30833792 | ||
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 5.11e-04 | 219 | 25 | 3 | 31353912 | |
| Pubmed | 5.31e-04 | 1487 | 25 | 6 | 33957083 | ||
| Pubmed | 5.53e-04 | 538 | 25 | 4 | 28524877 | ||
| Pubmed | 6.20e-04 | 234 | 25 | 3 | 36243803 | ||
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 6.28e-04 | 235 | 25 | 3 | 28378594 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 6.65e-04 | 565 | 25 | 4 | 25468996 | |
| Pubmed | 6.78e-04 | 568 | 25 | 4 | 37774976 | ||
| Pubmed | CIN85 interacting proteins in B cells-specific role for SHIP-1. | 6.94e-04 | 54 | 25 | 2 | 21725061 | |
| Interaction | RHOD interactions | 3.25e-06 | 572 | 24 | 7 | int:RHOD | |
| Interaction | RHOB interactions | 3.57e-06 | 840 | 24 | 8 | int:RHOB | |
| Interaction | RHOA interactions | 5.25e-06 | 1199 | 24 | 9 | int:RHOA | |
| Interaction | RHOF interactions | 9.46e-06 | 673 | 24 | 7 | int:RHOF | |
| Interaction | EPB41L4A interactions | 2.13e-05 | 140 | 24 | 4 | int:EPB41L4A | |
| Interaction | GSK3B interactions | 4.88e-05 | 868 | 24 | 7 | int:GSK3B | |
| Interaction | ACTA1 interactions | 6.56e-05 | 371 | 24 | 5 | int:ACTA1 | |
| Interaction | LAMP1 interactions | 8.56e-05 | 644 | 24 | 6 | int:LAMP1 | |
| Interaction | CLTC interactions | 9.40e-05 | 655 | 24 | 6 | int:CLTC | |
| Interaction | YWHAZ interactions | 9.41e-05 | 1319 | 24 | 8 | int:YWHAZ | |
| Interaction | TEDC2 interactions | 9.60e-05 | 206 | 24 | 4 | int:TEDC2 | |
| Interaction | RAB5A interactions | 1.42e-04 | 706 | 24 | 6 | int:RAB5A | |
| Interaction | RAC1 interactions | 1.75e-04 | 1063 | 24 | 7 | int:RAC1 | |
| Interaction | PCNT interactions | 1.76e-04 | 241 | 24 | 4 | int:PCNT | |
| Interaction | SCN2B interactions | 1.91e-04 | 95 | 24 | 3 | int:SCN2B | |
| Interaction | MYH9 interactions | 2.03e-04 | 754 | 24 | 6 | int:MYH9 | |
| Interaction | CFTR interactions | 2.10e-04 | 1480 | 24 | 8 | int:CFTR | |
| Interaction | YWHAQ interactions | 2.38e-04 | 1118 | 24 | 7 | int:YWHAQ | |
| Interaction | DIRAS3 interactions | 2.42e-04 | 262 | 24 | 4 | int:DIRAS3 | |
| Interaction | CNTNAP4 interactions | 3.09e-04 | 22 | 24 | 2 | int:CNTNAP4 | |
| Interaction | RAB28 interactions | 3.69e-04 | 24 | 24 | 2 | int:RAB28 | |
| Interaction | CDC5L interactions | 4.00e-04 | 855 | 24 | 6 | int:CDC5L | |
| Interaction | SAP18 interactions | 4.30e-04 | 305 | 24 | 4 | int:SAP18 | |
| Interaction | YWHAG interactions | 4.67e-04 | 1248 | 24 | 7 | int:YWHAG | |
| Interaction | TACSTD2 interactions | 4.70e-04 | 129 | 24 | 3 | int:TACSTD2 | |
| GeneFamily | Myosin heavy chains | 4.98e-05 | 15 | 13 | 2 | 1098 | |
| GeneFamily | EF-hand domain containing | 1.04e-02 | 219 | 13 | 2 | 863 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-04 | 178 | 25 | 3 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-04 | 181 | 25 | 3 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-04 | 182 | 25 | 3 | 678eadd57e7e830fc2bf9fd35616d3badce01705 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-04 | 182 | 25 | 3 | 8d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-04 | 186 | 25 | 3 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.52e-04 | 187 | 25 | 3 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.59e-04 | 190 | 25 | 3 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.62e-04 | 191 | 25 | 3 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.64e-04 | 192 | 25 | 3 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 192 | 25 | 3 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.64e-04 | 192 | 25 | 3 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.67e-04 | 193 | 25 | 3 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | (05)_Secretory-(0)_Reference|(05)_Secretory / shred by cell type by condition | 1.74e-04 | 196 | 25 | 3 | 7cb79cf122852c971f2d6e8d1e2b26eade891e83 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.74e-04 | 196 | 25 | 3 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-04 | 197 | 25 | 3 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.80e-04 | 198 | 25 | 3 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.80e-04 | 198 | 25 | 3 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | VE-CD4-exh_CD4|VE / Condition, Cell_class and T cell subcluster | 1.82e-04 | 199 | 25 | 3 | 6b00a393ad06ae91bf135a54a53ad4de68956193 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-04 | 199 | 25 | 3 | 3cd6383c50ce342fe5c175e2e50784d634a90e80 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.85e-04 | 200 | 25 | 3 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.85e-04 | 200 | 25 | 3 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.85e-04 | 200 | 25 | 3 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.85e-04 | 200 | 25 | 3 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.85e-04 | 200 | 25 | 3 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.85e-04 | 200 | 25 | 3 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| Computational | Actin cytoskeleton binding. | 5.76e-04 | 30 | 13 | 2 | MODULE_524 | |
| Computational | Genes in the cancer module 419. | 7.41e-04 | 34 | 13 | 2 | MODULE_419 | |
| Drug | AC1N9ZZC | 1.42e-05 | 149 | 23 | 4 | CID004369374 | |
| Drug | Trimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 4.32e-05 | 198 | 23 | 4 | 7235_DN | |
| Drug | Milrinone [78415-72-2]; Down 200; 19uM; PC3; HT_HG-U133A | 4.40e-05 | 199 | 23 | 4 | 5856_DN | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 4.40e-05 | 199 | 23 | 4 | 3640_UP | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Up 200; 12uM; MCF7; HT_HG-U133A | 4.40e-05 | 199 | 23 | 4 | 5433_UP | |
| Disease | motor function measurement, response to levodopa | 3.80e-06 | 4 | 24 | 2 | EFO_0010747, EFO_0010749 | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 2.84e-05 | 10 | 24 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 2.84e-05 | 10 | 24 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 2.84e-05 | 10 | 24 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 2.84e-05 | 10 | 24 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 2.84e-05 | 10 | 24 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 2.84e-05 | 10 | 24 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 2.84e-05 | 10 | 24 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 2.84e-05 | 10 | 24 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 4.16e-05 | 12 | 24 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 4.16e-05 | 12 | 24 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 4.92e-05 | 13 | 24 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 6.61e-05 | 15 | 24 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | protein C measurement | 8.56e-05 | 17 | 24 | 2 | EFO_0004633 | |
| Disease | myopathy (implicated_via_orthology) | 6.99e-04 | 48 | 24 | 2 | DOID:423 (implicated_via_orthology) | |
| Disease | Alzheimer disease, polygenic risk score | 1.19e-03 | 586 | 24 | 4 | EFO_0030082, MONDO_0004975 | |
| Disease | cancer (implicated_via_orthology) | 1.30e-03 | 268 | 24 | 3 | DOID:162 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 1.52e-03 | 71 | 24 | 2 | DOID:0050700 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.93e-03 | 80 | 24 | 2 | DOID:12930 (implicated_via_orthology) | |
| Disease | congestive heart failure (biomarker_via_orthology) | 3.41e-03 | 107 | 24 | 2 | DOID:6000 (biomarker_via_orthology) | |
| Disease | treatment-resistant hypertension | 3.54e-03 | 109 | 24 | 2 | EFO_1002006 | |
| Disease | endometrial carcinoma | 3.80e-03 | 113 | 24 | 2 | EFO_1001512 | |
| Disease | Adenocarcinoma | 4.00e-03 | 116 | 24 | 2 | C0001418 | |
| Disease | Carcinoma, Granular Cell | 4.00e-03 | 116 | 24 | 2 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 4.00e-03 | 116 | 24 | 2 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 4.00e-03 | 116 | 24 | 2 | C0205642 | |
| Disease | Carcinoma, Cribriform | 4.00e-03 | 116 | 24 | 2 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 4.00e-03 | 116 | 24 | 2 | C0205641 | |
| Disease | melanoma | 4.70e-03 | 126 | 24 | 2 | EFO_0000756 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RLRAFQAMQVHCNNM | 276 | Q08345 | |
| GNMNQNQRLDAMAKL | 341 | Q9UHI6 | |
| QRAQIHMREQMDNAV | 431 | Q96TA1 | |
| FGLRLNHAQQQMKMT | 796 | Q9NU22 | |
| FKHNNMASFVRQLNM | 61 | Q00613 | |
| NAYNDMLRNRDNQSM | 201 | A7E2Y1 | |
| HHLDQIREAMNRMQN | 1826 | Q8IVL0 | |
| LNEMEIQLNHANRMA | 1626 | P12882 | |
| MMKARHQELLSQQQN | 3811 | Q9UPN3 | |
| MNKLNFHNNRVMQDR | 1 | Q96NE9 | |
| MGQLQDQQALRHMQA | 736 | O75146 | |
| FIMRRNTAMQNLAQH | 241 | Q2WGN9 | |
| MEKLNNLHVQRADMN | 16 | Q9NWU2 | |
| NLHVQRADMNRLIMN | 21 | Q9NWU2 | |
| QMEMRHAQREQELQQ | 1321 | Q5TB80 | |
| RREMEQSMNMLNSNH | 191 | Q9NPA0 | |
| QFQMNHSVLQKARDM | 246 | Q86SQ9 | |
| MFGKVAMRDNNQINR | 1371 | Q01668 | |
| MAQHQKHENQMRDLQ | 1121 | Q9H2G2 | |
| HHFRQQRVAMMMQQQ | 1236 | Q9Y6Q9 | |
| GMRMQHNLEQQIQAR | 2301 | Q13813 | |
| LQQQQKHENQMRDML | 856 | O94804 | |
| NNMAMALHRQQCRVL | 1021 | P27708 | |
| MCENHRNLNMATNRI | 151 | A0A3B3IT33 | |
| HMNRLQSQRAMLLQG | 121 | Q9UEU0 | |
| AFNDMNPFRMKQLRQ | 866 | Q9BYX2 |